We are live on ! Find out more
MCI

McDonald Capital Investors Portfolio holdings

AUM $1.37B
1-Year Est. Return 1.88%
This Fund
S&P 500
This Quarter Est. Return
+4.18%
1 Year Est. Return
-1.88%
3 Year Est. Return
+60.24%
5 Year Est. Return
+91.56%
10 Year Est. Return
+335.97%
AUM
$1.23B
AUM Growth
-$1.98M
Cap. Flow
-$41.7M
Cap. Flow %
-3.38%
Top 10 Hldgs %
89.72%
Holding
24
New
3
Increased
Reduced
14
Closed
1

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.28M
2
GGP
GGP Inc.
GGP
+$2.5M
3
XL
XL Group Ltd.
XL
+$301K

Top Sells

Rank Stock Value
1
SRCL
Stericycle Inc
SRCL
+$10.1M
2
PGR icon
Progressive
PGR
+$4.92M
3
EXPD icon
Expeditors International
EXPD
+$4.57M
4
PAYX icon
Paychex
PAYX
+$4.41M
5
ECL icon
Ecolab
ECL
+$3.96M

Sector Composition

Rank Sector Weight
1 Financials 28.71%
2 Industrials 28.05%
3 Technology 12.41%
4 Materials 9.64%
5 Consumer Discretionary 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGR icon
1
Progressive
PGR
$122B
$185M 14.96%
3,120,647
-80,365
-3% -$4.92M
PAYX icon
2
Paychex
PAYX
$42B
$138M 11.16%
2,014,668
-68,280
-3% -$4.41M
EXPD icon
3
Expeditors International
EXPD
$21.9B
$129M 10.42%
1,757,938
-65,341
-4% -$4.57M
ECL icon
4
Ecolab
ECL
$78.1B
$119M 9.64%
847,501
-27,465
-3% -$3.96M
WFC icon
5
Wells Fargo
WFC
$262B
$107M 8.64%
1,923,592
-59,840
-3% -$3.21M
FAST icon
6
Fastenal
FAST
$55B
$104M 8.47%
8,684,552
-246,160
-3% -$3.19M
NKE icon
7
Nike
NKE
$62.7B
$96.6M 7.83%
1,212,597
-49,221
-4% -$3.47M
UNP icon
8
Union Pacific
UNP
$172B
$85.8M 6.95%
605,285
-19,275
-3% -$2.69M
CMCSA icon
9
Comcast
CMCSA
$87.1B
$81.5M 6.61%
2,483,995
-68,735
-3% -$2.24M
BN icon
10
Brookfield
BN
$106B
$62.2M 5.04%
4,300,715
-125,955
-3% -$1.8M
CLB icon
11
Core Laboratories
CLB
$492M
$40M 3.24%
316,887
-7,306
-2% -$889K
CAH icon
12
Cardinal Health
CAH
$54.5B
$33.9M 2.75%
694,900
-20,585
-3% -$1.17M
SRCL
13
DELISTED
Stericycle Inc
SRCL
$27.3M 2.21%
417,695
-162,415
-28% -$10.1M
ROP icon
14
Roper Technologies
ROP
$38.8B
$15.5M 1.25%
56,005
-1,195
-2% -$330K
REGN icon
15
Regeneron Pharmaceuticals
REGN
$78.5B
$3.62M 0.29%
+10,500
New +$3.28M
GGP
16
DELISTED
GGP Inc.
GGP
$2.52M 0.2%
+123,400
New +$2.5M
WFC.WS
17
DELISTED
Wells Fargo & Company Ws
WFC.WS
$1.32M 0.11%
60,000
TBF icon
18
ProShares Short 20+ Year Treasury ETF
TBF
$105M
$1.22M 0.1%
54,000
USB icon
19
US Bancorp
USB
$98.5B
$483K 0.04%
9,649
XL
20
DELISTED
XL Group Ltd.
XL
$302K 0.02%
+5,400
New +$301K
OUT icon
21
Outfront Media
OUT
$5.55B
$243K 0.02%
12,700
RSP icon
22
Invesco S&P 500 Equal Weight ETF
RSP
$97.7B
$209K 0.02%
2,050
TBT icon
23
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$316M
$203K 0.02%
5,650
BUFF
24
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
-21,500
Closed -$856K

Similar funds

McDonald Capital Investors's Q2 2018 Portfolio in Review

As of Q2 2018, McDonald Capital Investors held 24 positions worth $1.23B, down 0.16% from $1.24B the previous quarter. Its ten largest holdings account for 90% of the portfolio.

McDonald Capital Investors withdrew a net $41.7M in Q2 2018, closing 1 position and reducing 14 holdings. Its most notable exit was Blue Buffalo Pet Products, Inc, an estimated $856K position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

Against the trend, McDonald Capital Investors opened a new position in Regeneron Pharmaceuticals worth $3.62M.

  • McDonald Capital Investors's largest Q2 2018 buy was Regeneron Pharmaceuticals: 10,500 shares worth $3.62M.
  • McDonald Capital Investors's biggest Q2 2018 reduction was Stericycle Inc, cutting an estimated $10.1M.
  • McDonald Capital Investors fully exited Blue Buffalo Pet Products, Inc in Q2 2018, selling an estimated $856K.
  • McDonald Capital Investors's ten largest holdings make up 90% of its $1.23B portfolio in Q2 2018.
  • McDonald Capital Investors opened 3 new positions and closed 1 in Q2 2018.
  • McDonald Capital Investors's portfolio value fell 0.16% quarter-over-quarter to $1.23B.

Based on McDonald Capital Investors's 13F filing for Q2 2018, filed 30 Jul 2018.